IMPERIAL BRANDS PLC
Legal Entity Identifier (LEI) No. 549300DFVPOB67JL3A42
FULL YEAR RESULTS STATEMENT
17 NOVEMBER 2026
Delivering superior returns
Building scale in next generation products
Report for the year ended 30 September 2026
Business highlights*
Sixth consecutive year of broad-based growth; delivering on strategic priorities.
Tobacco net revenue growth of 1.7% (reported tobacco revenue declined -5.0%).
Next Generation Products net revenue up 11.4%, third year of market share growth in all three categories (reported NGP revenue growth +17.8%).
Distribution adjusted operating profit up 4.1% reflecting recovery in Transport (reported operating profit up 2.0%).
Adjusted operating profit up 3.7% (reported operating profit down 10.2%, reflecting strategic investments and Delaware settlement).
Adjusted earnings per share up 8.8% driven by adjusted operating profit growth and share count reduction (reported earnings per share declined -3.3%, largely driven by operating profit).
Strong cash generation, with free cash flow of £2.6bn.
Increased capital returns: FY26 dividend per share up 4% and £1.5bn share buyback for FY27 commenced.
Growing momentum behind transformation; on track to deliver at least £320m of annual cost savings by 2030.
* All measures at constant currency unless otherwise stated.
Financial summary
Twelve months ended 30 September 2026 | Reported | Adjusted2 | |||||||
2026 | 2025 | Change | 2026 | 2025 | Actual | Constant currency3 | |||
Revenue | £m | 31,677 | 32,171 | -1.5% | – | – | – | – | |
Tobacco & NGP net revenue1 | £m | – | – | – | 8,506 | 8,316 | +2.3% | +2.1% | |
Tobacco & NGP operating profit | £m | 2,819 | 3,178 | -11.3% | 3,789 | 3,665 | +3.4% | +3.7% | |
Operating profit | £m | 3,134 | 3,490 | -10.2% | 4,130 | 3,988 | +3.6% | +3.7% | |
Earnings per share | P | 242.9 | 251.1 | -3.3% | 341.0 | 315.0 | +8.3% | +8.8% | |
Net debt | £m | (9,126) | (8,954) | – | (8,786) | (8,406) | – | – | |
Dividend per share | P | 166.72 | 160.32 | +4.0% | 166.72 | 160.32 | +4.0% | +4.0% | |
- Tobacco & NGP net revenue is reported revenue less duty and similar items and sale of peripheral products and Distribution (Logista) revenue.
- See page 3 for the basis of presentation and the supplementary section at the end of the financial statements for the reconciliation between reported and adjusted measures.
- Constant currency removes effect of exchange rate movements on the translation of the results of our overseas operations.
Lukas Paravicini, Chief Executive Officer
“We continue to perform and transform. This is our sixth consecutive year of growth in tobacco & NGP net revenue and adjusted operating profit. In NGP, once again we grew net revenues at double digit and market share in all categories. At the same time, we have made tangible progress on our transformation to become more consumer-centric, agile, data led and efficient.
“In combustibles, we successfully managed market share, pricing and volumes to deliver sustainable, growing revenue and profit. Our long-term investments in brands and sales execution continue to drive growth in the US and Germany, our two largest markets, as well as broad-based delivery across other market clusters. In NGP our strong organic growth was supported by the acquisitions of Black Buffalo in the US and Helwit in Sweden.
“While continuing to invest in and build future consumer capabilities, underpinned by new technologies, we are confident of achieving at least £320 million of annual savings by 2030. We have delivered annualised savings of £90 million, with actions taken since the programme began supporting future annualised savings of £180 million – more than half of our target.
“Our strategy continues to deliver superior returns, with our FY26 share buyback of £1.45 billion completed, 4% annual growth in our dividend per share, and an increase in our share buyback for FY27 to £1.5 billion. Our expectations for the coming year are in line with our medium-term guidance.”
Operational highlights
Driving sustainable value in combustibles
Strong performance across all key markets resulted in tobacco net revenue growth of 1.7%, driven by pricing of +5.1% offsetting volume declines of -3.4%
Americas delivered strong tobacco net revenue growth of +3.3%, reflecting robust pricing and improving market volume dynamics
Europe managed volume, value and share across the portfolio, with tobacco net revenue declining -0.5%; excluding private label, tobacco net revenue grew +0.4%, reflecting good execution in Germany and UK and strong performance from market clusters.
AAACE, tobacco net revenue grew 2.9% reflecting strong performances in Africa, Asia Middle East & Turkey market clusters, offset by performance in Australia. Excluding Australia, tobacco net revenue in AAACE grew 7.6%
Aggregate cigarette volume share across US, Germany, Spain, UK and Australia down –15bps, similar to position at half year
Building scale in Next Generation Products
Multi-category approach delivering market share gains in all three categories and strong volume growth in all regions; another year of double-digit net revenue growth; growing profitability in Europe
In modern oral, Zone in US continuing to deliver strong volume growth, with addition of Black Buffalo addressing complementary consumer segments; in Nordics new product launches in Skruf and Zone performing well and acquisition of Helwit expands our portfolio; in UK Zone growing share
New pod-based blu bar and blu kit ranges performing well as markets continue to transition to rechargeable systems across Europe; growing market share in UK, France, Germany and New Zealand; double-digit market shares in UK, France and Spain.
Heated product sales growing strongly, driven by Pulze 3.0 and new iD sticks, particularly in Italy, Poland, Czechia and Greece.
New ‘Smokeless’ category from FY27, including both NGP and traditional oral nicotine delivery (TOND) business in Nordics; in FY26 TOND delivered £135 million net revenue and £77 million adjusted operating profit, equating to FY26 Smokeless category with £554 million net revenue and adjusted operating profit of £14 million
Progress on Transformation
Confident of achieving at least £320m cost savings per annum by 2030
Delivered £90m of annualised savings in FY26; actions taken since the transformation programme began support future annualised future savings of £180m
Strong momentum behind manufacturing footprint rationalisation; completed consultation in Langenhagen
Continuing to invest in our consumer capabilities and new technologies; Strategic partnership with Capgemini to support growth and deliver efficiencies: continued rollout of enterprise platforms. Go-live of our new ERP platform in Australasia and our Radom manufacturing facility in Poland
During FY26, we completed programmes that will lead to a reduction of 2,100 roles globally, and we expect a further reduction of between 2,100 and 2,500 roles by the end of 2030. Throughout this transformation, we are committed to following appropriate consultation processes and supporting our people
Financial delivery*
Tobacco & NGP net revenue growth driven by resilient tobacco pricing
Tobacco volumes down -3.4% (to 180.6bn SE) driven by declines in Europe, reflecting the planned reduction in German private label production due to the closure of the Langenhagen factory, together with market declines and improving market backdrop in the US and growth in our AAACE region
Solid tobacco pricing of 5.1% delivered tobacco net revenue growth of 1.7%
NGP net revenue up 11.4% as strong growth in Europe and AAACE more than offset declines in US as we withdrew our legacy myblu vape from the market
Tobacco & NGP net revenue up 2.1%, driven by a broad base of markets
Reported tobacco & NGP revenue declined -4.6%, reflecting lower excise taxes due to volume declines in high excise markets such as Australia and the UK, and the reduction in German private label production, partly offset by stronger tobacco volume in our AMET and African market clusters and NGP growth
Delivering growth in adjusted operating profit
Group adjusted operating profit grew 3.7% on prior year, driven primarily by improved profitability in tobacco
Reported operating profit declined -10.2% reflecting higher costs relating to the Delaware settlement charges and 2030 Strategy activities
Tobacco adjusted operating profit increased 3.5%, driven by pricing offsetting volume declines and increased investment; reported tobacco operating profit declined -12.3% due to costs associated with the Delaware settlement and implementation of 2030 Strategy
NGP adjusted operating loss of £63m, a £5m improvement on prior year, reflecting growing profitability in Europe, offset by the inclusion of Black Buffalo in the US; reported NGP operating losses declined £48m, reflecting, lower amortisation of intangibles and the impact of the fair value assessment of Auxly, offset by costs relating to transitioning myblu out of the US market
Distribution adjusted operating profit including eliminations increased 3.1%, driven by an improvement in long-distance transportation
Adjusted EPS grew by 8.8% reflecting an increase in earnings of 3.0% and reduced share count more than offsetting increased finance charges and higher tax and minority interest costs
Reported EPS declined -3.3% as a result of lower operating profits due to the Delaware settlement and 2030 Strategy costs and higher financing costs offset by a lower tax charge and reduced share count due to the ongoing share buyback
Free cash flow supporting investment and shareholder returns
Free cash flow of £2.6bn, reflecting adjusted operating cash conversion of c.102%
Adjusted net debt £8.8bn (FY25: £8.4bn); adjusted net debt to EBITDA at 2.0x (FY25: 2.0x); reported net debt £9.1bn (FY25: £9.0bn).
FY26 dividend per share up 4.0% to 166.72 pence, in line with our progressive dividend policy
Ongoing, multi-year evergreen buyback: FY26 £1.45bn completed; £1.5bn underway for FY27, reflecting confidence in future performance
Cumulative capital returns from FY21 to FY26 of over £13bn, representing over 21% of issued share capital since the buyback commenced in October 2022
* All measures at constant currency unless otherwise stated.
OUTLOOK
Our expectations for the coming year are in line with the medium-term guidance set out at our Capital Markets Day in March 2025. On a constant currency basis, we expect to deliver low-single-digit tobacco and double-digit NGP net revenue growth. Tobacco pricing will continue to more than offset cigarette volume declines and in NGP we will continue to focus on and invest in the most relevant profit pools in our accessible footprint, maintaining double digit growth through consumer-focused innovation and consumer acquisition. In FY27, we will combine our traditional oral nicotine and NGP net revenue and adjusted operating profit and refer to it as “Smokeless”. For FY27, Group adjusted operating profit is expected to grow at a similar level to FY26, on a constant currency basis, primarily driven by continued profit growth from our combustible tobacco business. The usual second half weighting of performance is expected to be more pronounced than in FY26. Headwinds caused by disruption to our supply chain in Ukraine, the result of an attack on our facilities, will have a short-term impact during the first half of FY27, whilst the benefits of pricing, transformation efficiencies and duty drawback in the US will be weighted to the second half. After 2030 Strategy costs, including the closure of our Langenhagen factory during the year, and the second instalment of the Delaware settlement, we expect to generate free cash flow of at least £2.2 billion in FY27, in line with the guidance provided at the Capital Markets Day in March 2025. We expect FY27 to be a significant year for 2030 Strategy cash costs. Growth in adjusted operating profit combined with the impact of our ongoing share buyback is expected to result in at least high single-digit adjusted earnings per share for the full year. At current rates, foreign exchange translation is expected to be a headwind of 0.5% to 1.5% to net revenue, adjusted operating profit and earnings per share. The geopolitical and macroeconomic backdrop continues to be uncertain, with the potential future impact of the Middle East conflict, on both costs and consumer behaviour, remaining difficult to assess. However, the power of our brands, depth of our portfolios and diverse growth levers across our global markets mean we are well placed to navigate any future volatility. |
For a Copy of the full statement
To view a copy of the full statement please click here: http://www.rns-pdf.londonstockexchange.com/rns/3914D_1-2026-11-16.pdf
Basis of Presentation
To aid understanding of our results, we use ‘adjusted’ (non-GAAP) measures to provide a consistent comparison of performance from one period to the next. Reconciliations between adjusted and reported (GAAP) measures and further definitions of adjusted measures are provided in the supplementary information section. Change at constant currency removes the effect of exchange rate movements on the translation of the results of our overseas operations. References in this document to percentage growth and increases or decreases in our adjusted results are on a constant currency basis unless stated otherwise. These are calculated by translating current year results at prior year exchange rates.
Stick Equivalent (SE) volumes reflect our combined cigarette, fine cut tobacco, cigar and snus volumes but exclude any NGP volume such as heated tobacco, modern oral nicotine and vapour.
Market share is presented as a 12-month average to the end of September (MAT – moving annual trend), unless otherwise stated. Aggregate market share is a weighted average across markets within our footprint.
Other Information
Investor Contacts | Media Contacts | ||
John Crosse | +44 (0)7484 967 842 | Jonathan Oliver | +44 (0)7740 096 018 |
Jennifer Ramsey | +44 (0)7974 615 739 | Simon Evans | +44 (0)7967 467 684 |
Henry Dodd | +44 (0)7941 648 421 |
Analyst Presentation Webcast
Lukas Paravicini, Chief Executive Officer, and Murray McGowan, Chief Financial Officer, will present the results to investors and analysts via a webcast at 09:00 (GMT) on 17 November 2026. The presentation slides will be available from 07.00 (GMT) on www.imperialbrandsplc.com. A webcast recording and presentation script will be available after the webcast has concluded.
The webcast will be available on https://edge.media-server.com/mmc/p/xo6yaq4p. To participate in the Q&A session, please register in advance via this link https://register-conf.media-server.com/register/BI5b22b8df500142958edd79fe41c1be92. You will then receive the dial-in details and your own PIN to access the live Q&A session.
Cautionary Statement
Certain statements in this announcement constitute or may constitute forward-looking statements. Any statement in this announcement that is not a statement of historical fact including, without limitation, those regarding the Company’s future expectations, operations, financial performance, financial condition and business is or may be a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected or implied in any forward-looking statement. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this announcement. As a result, you are cautioned not to place any reliance on such forward-looking statements. The forward-looking statements reflect knowledge and information available at the date of this announcement and the Company undertakes no obligation to update its view of such risks and uncertainties or to update the forward-looking statements contained herein. Nothing in this announcement should be construed as a profit forecast or profit estimate and no statement in this announcement should be interpreted to mean that the future earnings per share of the Company for current or future financial years will necessarily match or exceed the historical or published earnings per share of the Company. This announcement has been prepared for, and only for the members of the Company, as a body, and no other persons. The Company, its Directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom this announcement is shown or into whose hands it may come, and any such responsibility or liability is expressly disclaimed.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
